Skip to main content

Table 2 Correlation between VASH2 and histopathologic features in 102 cases of pancreatic cancer

From: Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2

Category

n (%)

VASH2 staining (%)

P value1

Negative/weak

Middle/strong

Adjacent tissues

102

77(75.5)

25(24.5)

0.001

Cancer tissue

102

44(43.1)

58(56.9)

Tumor Grade

 G1-G2

48 (47.1)

27(56.2)

21(43.8)

0.012

 G3

54 (52.9)

17(31.5)

37(68.5)

Pathologic stage

 T1-2

15(14.7)

5(33.3)

10(66.7)

0.406

 T3-4

87(85.3)

39(44.8)

48(55.2)

Node status

 Negative

57(55.9)

20(35.1)

37(64.9)

0.065

 Positive

45(44.1)

24(53.3)

21(46.7)

Nerve status

 Negative

34(33.3)

16(47.1)

18(52.9)

0.572

 Positive

68(66.7)

28(41.2)

40(58.8)

Vessel cancerous embolus

 Negative

89(87.3)

42(47.2)

47(52.8)

0.031

 Positive

13(12.7)

2(15.4)

11(84.6)

  1. 1Pearson’s chi-square test p-value